Innovation is our driving force to fullfill clinicians and patients needs exactly to the point. With our products and solutions, we ensure reliable treatment results in almost all indications. Botiss Benelux is a reseller of Botiss products in the Netherlands, Belgium and Luxemburg!
Mark your calendar and save the date: November 13, 2027.
The coming edition has already been announced. Following Knokke 2025 and Antwerp 2026, the next chapter will again be all about education, science, innovation, regeneration, and fun. More information will be shared in the coming months.
With 50% of the 120-plus employees being scientists, botiss is constantly investing in research and further education. Unique innovations, the concept of high-quality learning and education with the botiss academy, and the international bone & tissue days are the results of our partnership with worldwide renowned academic research institutes, global opinion leaders, and practitioners in their daily clinical environment.
"Products from botiss are perfectly designed to match one another and to be used in combination for every single clinical situation, from sinus lift to horizontal/vertical augmentations or the improvement of the soft tissue quality."
Dr. Marius Steigmann Steigmann Institute
"mucoderm® is a material that is so easy to stabilize in term of a suturing technique."
Prof. Giovanni Zucchelli Italy
"Due to its high biocompatibility and excellent mechanical properties mucoderm® is perfectly suitable."
Prof. Anton Sculean Switzerland
"Excellent alternative which can provide similar results at a fraction of time of surgery."
Dr. Hassan Maghaireh United Kingdom
"The mucoderm® matrix is a viable, highly safe and patient-friendly alternative to palatal donor tissue."
Prof. Dr. Adrian Kasaj Germany
"I have been using mucoderm® for over seven years, and it has become one of my most trusted biomaterials."
Sheylla Brito United Kingdom
"mucoderm® is a fabulous alternative to connective tissue grafting."
Erick Mota Dominican Republic
Since the foundation of botiss biomaterials in 2009, botiss has become a leading developer, manufacturer and marketer of biomaterials for oral tissue regeneration.
Botiss is constantly investing in research and education. We act as a link between developers, researchers and clinicians, with a key focus on the daily practical experience.
The indication-oriented products are used worldwide in over 100 countries and are supported by both clinical studies and many years of clinical experience.
Our products have proven safety, efficacy and reliability in preclinical and clinical studies and in daily clinical work. We have 100 thousands of patients worldwide.
